- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH) ; volume:8 ; number:1 ; day:14 ; month:11 ; year:2008 ; pages:1-9 ; date:12.2008
BMC gastroenterology ; 8, Heft 1 (14.11.2008), 1-9, 12.2008
- Creator
-
Yoneda, Masato
- Contributor
-
Uchiyama, Takashi
Kato, Shingo
Endo, Hiroki
Fujita, Koji
Yoneda, Kyoko
Mawatari, Hironori
Iida, Hiroshi
Takahashi, Hirokazu
Kirikoshi, Hiroyuki
Inamori, Masahiko
Nozaki, Yuichi
Kobayashi, Noritoshi
Kubota, Kensuke
Saito, Satoru
Maeyama, Shiro
Sagara, Mina
Aburatani, Hiroyuki
Kodama, Tatsuhiko
Nakajima, Atsushi
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-8-53
- URN
-
urn:nbn:de:1111-201607153014
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoneda, Masato
- Uchiyama, Takashi
- Kato, Shingo
- Endo, Hiroki
- Fujita, Koji
- Yoneda, Kyoko
- Mawatari, Hironori
- Iida, Hiroshi
- Takahashi, Hirokazu
- Kirikoshi, Hiroyuki
- Inamori, Masahiko
- Nozaki, Yuichi
- Kobayashi, Noritoshi
- Kubota, Kensuke
- Saito, Satoru
- Maeyama, Shiro
- Sagara, Mina
- Aburatani, Hiroyuki
- Kodama, Tatsuhiko
- Nakajima, Atsushi
- SpringerLink (Online service)
Other Objects (12)
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)